Your browser doesn't support javascript.
loading
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip, Enriqueta; Altorki, Nasser; Zhou, Caicun; Csoszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan; Yi, Jing; Deng, Yu; McCleland, Mark; Bennett, Elizabeth; Gitlitz, Barbara; Wakelee, Heather.
Afiliação
  • Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: efelip@vhio.net.
  • Altorki N; Division of Thoracic Surgery, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.
  • Zhou C; Department of Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.
  • Csoszi T; Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Rendelointézet, Szolnok, Hungary.
  • Vynnychenko I; Regional Municipal Institution Sumy Regional Clinical Oncology Dispensary, Sumy State University, Sumy, Ukraine.
  • Goloborodko O; MI Zaporizhzhia Regional Clinical Oncological Dispensary Zaporizhzhia SMU Ch of Oncology, Zaporizhzhya, Ukraine.
  • Luft A; Department of Thoracic Surgery, Leningrad Regional Clinical Hospital, Saint Petersburg, Russia.
  • Akopov A; Research Institute of Pulmonology, Pavlov State Medical University, Saint Petersburg, Russia.
  • Martinez-Marti A; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Kenmotsu H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Chen YM; Department of Chest Medicine, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chella A; Pneumology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
  • Voong D; Genentech, South San Francisco, CA, USA.
  • Wu F; Roche (China) Holding, Shanghai, China.
  • Yi J; Genentech, South San Francisco, CA, USA.
  • Deng Y; Genentech, South San Francisco, CA, USA.
  • McCleland M; Genentech, South San Francisco, CA, USA.
  • Bennett E; Genentech, South San Francisco, CA, USA.
  • Gitlitz B; Genentech, South San Francisco, CA, USA.
  • Wakelee H; Department of Medicine, Division of Oncology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA.
Lancet ; 398(10308): 1344-1357, 2021 10 09.
Article em En | MEDLINE | ID: mdl-34555333
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article